Morgan Stanley cut shares of Smith & Nephew SNATS (NYSE:SNN) from an overweight rating to an equal weight rating in a research report sent to investors on Monday morning, Marketbeat reports.

Several other brokerages also recently commented on SNN. Zacks Investment Research upgraded shares of Smith & Nephew SNATS from a hold rating to a buy rating and set a $43.00 target price on the stock in a report on Wednesday, October 18th. Canaccord Genuity initiated coverage on shares of Smith & Nephew SNATS in a report on Wednesday, October 11th. They issued a buy rating and a $42.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of $42.50.

Smith & Nephew SNATS (NYSE:SNN) opened at $35.40 on Monday. Smith & Nephew SNATS has a twelve month low of $29.51 and a twelve month high of $40.43. The company has a quick ratio of 1.08, a current ratio of 2.18 and a debt-to-equity ratio of 0.38.

Several large investors have recently bought and sold shares of SNN. Morgan Stanley increased its holdings in shares of Smith & Nephew SNATS by 83.9% during the 1st quarter. Morgan Stanley now owns 122,149 shares of the medical equipment provider’s stock worth $3,777,000 after purchasing an additional 55,720 shares during the period. Bank of Montreal Can increased its holdings in shares of Smith & Nephew SNATS by 2.4% during the 2nd quarter. Bank of Montreal Can now owns 23,873 shares of the medical equipment provider’s stock worth $831,000 after purchasing an additional 558 shares during the period. First Trust Advisors LP bought a new position in shares of Smith & Nephew SNATS during the 2nd quarter worth about $327,000. Wrapmanager Inc. increased its holdings in shares of Smith & Nephew SNATS by 2.1% during the 2nd quarter. Wrapmanager Inc. now owns 10,178 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 207 shares during the period. Finally, SG Americas Securities LLC bought a new position in shares of Smith & Nephew SNATS during the 2nd quarter worth about $641,000. Institutional investors own 6.63% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Smith & Nephew SNATS (SNN) Cut to Equal Weight at Morgan Stanley” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/smith-nephew-snats-snn-cut-to-equal-weight-at-morgan-stanley/1762917.html.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.